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Abstract
The increasing prevalence of advanced chronic respiratory disease, with frequent exposure to broad-spectrum antibiotics for repeated and
prolonged hospitalizations, favours the emergence of nosocomial respiratory infection by Gram-positive bacteria, such as outbreaks of
Corynebacterium striatum. There is little evidence about patterns of respiratory infection, transmission and adaptive ability of this pathogen.
Seventy-two C. striatum isolates from 51 advanced respiratory patients, mainly chronic obstructive pulmonary disease, were studied during
38 months. Patients were 74.8  8.6 years old and 81.9% were men, who had required an average of 2.2 hospitalizations and 63.5 days in
the hospital in the previous year. Of 49 isolates from 42 patients we were able to identify 12 clones by multilocus sequence analysis (MLSA),
nine phenotypic variants and 22 antibiotic susceptibility patterns, and we determined their clinical and epidemiological determinants. MLSA
allows identiﬁcation of the existence of nosocomial outbreaks by transmission of the same or different clones, the persistence of the same
clone in the environment or in patient airways for months. The study showed the high variability and adaptive capacity of the isolates, the
antibiotic multidrug-resistance in all of them, and their contribution to a high morbidity and mortality (41%) during the study period.
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Introduction
Corynebacterium species are found colonizing skin, other
tissues, and in the environment [1,2]; they are considered
normal ﬂora and not potentially pathogenic. But in 1997 Funke
et al. [3] described a massive increase in the number of
publications related to this genus, which were attributed to the
increase of immunocompromised patients susceptible, to
improved microbiological diagnoses, and to a precise taxo-
nomic classiﬁcation that allows the correct identiﬁcation of
different species with different clinical expression.
In the last decades, in addition to Corynebacterium diphtheriae,
the pathogenicity amongCorynebacterium spp. has been reported
associated with Corynebacterium amycolatum [4,5], Corynebacte-
rium jeikeium, Corynebacterium macginleyi, Corynebacterium urea-
lyticum, Corynebacterium pseudodiphtheriticum and, less frequently
with Corynebacterium xerosis [4,6–8]. Corynebacterium striatum
has been reported colonizing prostheses, catheter tips, and
ventilator and feeding tubes, and it has been also identiﬁed as
causative in cases of endocarditis, sepsis and bacteraemia [9–11].
Until 1993 there were only three individual case reports of
conﬁrmed respiratory infections by C. striatum [12–14]. Since
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then, numerous individual cases and various nosocomial
infectious outbreaks of C. striatum have been reported [15–
21] mostly in patients with chronic diseases requiring frequent
and prolonged hospitalizations with repeated exposure to
antibiotics against Gram-negative bacteria, organic obstructive
disorders, or exposed to invasive procedures that disrupted
the skin barrier. Most reported C. striatum infections have
been found in respiratory samples, the vast majority of strains
being multidrug-resistant.
The study of nosocomial infections and outbreaks is
fundamental to have reliable methods for the identiﬁcation
and typing of the bacteria responsible. It allows further efforts
to prevent and control these events, and to reduce individual
and population burden. There are several available fast and
affordable methods that allow a good identiﬁcation of species
and useful for the identiﬁcation of an outbreak, but under-
standing the mechanisms and transmission circumstances
during an outbreak requires a molecular study of the isolates.
Several studies have tried to accomplish this objective
[16,19,21,22], but none of them employed a methodology
for identiﬁcation and typing of strains until the study of Gomila
et al. [23]. In that study, isolates of C. striatum were analysed
using different approaches, ribotyping, phenotype, matrix-as-
sisted laser desorption/ionization time-of-ﬂight mass spectros-
copy, and multilocus sequence analysis (MLSA). They
demonstrated that isolates of C. striatum were best identiﬁed
using gene-based molecular methods.
The main aim of this prospective study is to explore the
epidemiological and pathological circumstances of a group of
patients susceptible to be infected by C. striatum, managed in a
respiratory ward. We determined the genetic identity of
C. striatum strains isolated in cultures of biological samples
obtained during infectious respiratory exacerbations. We
aimed to study the clinical and environmental determinants,
the transmission mechanisms between patients, their adaptive
ability and variability in phenotype and susceptibility to
antibiotics, its ability to persist in the environment and
respiratory airways, and its impact on morbidity and mortality
in this group of patients.
Material and Methods
Corynebacterium striatum culture collection
The Hospital Joan March, in Bunyola, Mallorca, Spain, is a
secondary healthcare centre that hosts a convalescence and
rehabilitation department, with a 26-bed ward. It aims to
deliver care to patients with severe, chronic respiratory
disease referred from tertiary-care hospitals within its catch-
ment area.
Seventy-one C. striatum isolates from cultures of respiratory
samples, and one from a dermal ulcer, from 51 patients with
advanced respiratory disease seen in the hospital, were
obtained during 38 months (from May 2006 to June 2009),
and we explored their clinical and epidemiological determi-
nants. Forty-nine of these C. striatum isolates, from 42 patients,
could be recovered with the aim of analysing their antibiotic
susceptibility, phenotype and genotype.
All respiratory samples were obtained during respiratory
infectious exacerbations that fulﬁlled GOLD criteria [24], and
according to the criteria of Anthonisen et al. [25] were of
potential infectious origin. Specimens were cultured on
Columbia agar with 5% sheep blood (bioMerieux, Marcy
l’Etoile, France). Before processing, all samples were Gram-
stained so as to discard the samples not representative of the
lower respiratory tract and/or contaminated with microbiota
from the upper respiratory tract according to the Murray and
Washington criteria [26]. The clinical relevance of C. striatum
isolation from respiratory samples was based on their correct
identiﬁcation, their abundance, their isolation as a single
microorganism or their predominance when found in associ-
ation, and the repetition of positivity [1]. The processing and
incubation of plates was performed following routine labora-
tory conditions. All isolates were stored at 80°C for future
study.
Phenotypic and antibiotic susceptibility, and molecular
analysis
All information about phenotype, genotype and antibiotic
susceptibility was consistent with our previous work on 49
recovered isolates of the total 72 [23], and they were
labelled with alphabetical codes. Coding is described in Table
S1 (see the Supporting information). From the molecular
analysis only the internally transcribed spacer 1 (ITS1) region
and the gyrA and rpoB genes were used, as they were the
most useful for discriminating between strains due to their
variability.
Isolates versus temperature and humidity
Given that C. striatum is an environmental bacterium, temper-
ature and humidity were recorded on the date of obtaining
each isolate. Information was obtained from the ofﬁcial
weather station in the enclosed area of the hospital. For this
environmental analysis, the 43 isolates of C. striatum from a
previous outbreak that occurred in our hospital between
January 2004 and June 2005 were also considered [20].
Statistical analysis
Statistical analyses were performed using the SPSS v.15.0
software. All data were quality controlled and comprehensive
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tabulations with mean, standard deviation, and ranges for
quantitative variables, and counts and percentage of all
quantitative variables, were presented.
Results
Seventy-two C. striatum isolates were obtained during
38 months, mainly from cultures of respiratory samples of
51 patients, 81.9% men, with a mean age of 74.8 years. They
suffered an average of 2.2 hospitalizations and 63.5 hospital
days in the year before obtaining a positive culture. Overall,
84.7% had a diagnosis of chronic obstructive pulmonary
disease, with a mean  SD forced expiratory volume
(FEV1%) of 39.4  16.6%. Forty-nine percent of patients
died during follow up. A code was assigned to each patient,
from 1 to 51, sequentially by order of entry, and in patients
who showed more than one isolate, a letter was added to
the patient number in alphabetical order, from ‘a’ to ‘c’
(Table 1).
Bacteria description
Of 72 specimens, 71 corresponded to respiratory samples: 69
of spontaneous sputum, one bronchoaspirate, and one
tracheal aspirate, while the other specimen was from a dermal
ulcer smear.
Sixty-one C. striatum isolates were obtained from patients
hospitalized in the respiratory ward of our hospital, nine from
outpatients, three from patients hospitalized in different wards
of the same hospital, and two from a patient in the Hospital
General de Palma, who later became an outpatient of our
hospital (Fig. 1).
In 41 (56.9%) specimens, C. striatum isolates were in pure
culture, in 19 (26.4%) they were accompanied by Pseudomonas
aeruginosa, in six (8.3%) by Stenotrophomonas maltophilia, and by
other bacteria in six cases (8.3%). In 44 patients a single
C. striatum isolate was obtained, in 12 patients two were
obtained, in six patients three were obtained, and in two
patients four isolates were obtained; there was a trend that the
more repeat positive cultures, the greater the severity of
bronchial obstruction.
Antibiotic susceptibility
All isolates showed antibiotic multiresistance, deﬁned as
resistance to three or more different antibiotic families. All
isolates were resistant to ciproﬂoxacin, and all were sensitive
to vancomycin (16% sensitive to vancomycin, exclusively). The
percentage of sensitivity to the remaining antibiotics tested is
shown in Table S2 (see the Supporting information).
Identiﬁcation and labelling of clones
Ampliﬁcation and sequencing of the ITS1 region and the gyrA
and rpoB genes in 49 C. striatum isolates, allowed the identi-
ﬁcation of 12 different clones whose identity was simpliﬁed by
attributing a capital letter to each (see Supporting information,
Fig. S1).
Based on the phenotypic data, nine phenotypic variants
were determined, and are labelled with a lowercase letter
from ‘a’ to ‘k’. Twenty-two isolates (44.9%) corresponded to
phenotype ‘a’.
The same procedure was performed for the antibiotic
proﬁle. The combination of susceptible/intermediate/resistant
to the antibiotics tested (re-considering intermediate as
resistant), gave 22 different combinations. A lowercase letter
from ‘a’ to ‘z’ was also assigned to each combination. The most
common were ‘a’, sensitive only to vancomycin, in eight
(16.3%) isolates, and ‘b’, susceptible only to vancomycin and
gentamicin, in six (12.2%) isolates (Table 1 and see Supporting
information, Table S2).
Considering the nine phenotypic variants, the 12 genotype
combinations, and the 22 antibiotype combinations, 39 variants
in the 49 isolates were obtained. Nevertheless, ten isolates had
identical genotype, phenotype and susceptibility patterns in
different time, space and patients (Table 1).
Temporal and geographic distribution of the clones
The temporal and geographic distribution of the clones was
explored next (Fig. 1 and 2, Table 1). The isolates from
different patients whose genotype suggested greater temporal
and spatial relationships were the following: Clone A (patients
12 and 15, and patients 19, 24b and c) who shared rooms 117
and 123, respectively, in close time; Clone B (patients 20 and
21, and patients 31 and 39), who shared rooms 115 and 107,
respectively, but not simultaneously; and Clone C, which
displayed a remarkable mobility, from patient 44, to patients
45, 47 and 49, hospitalized in different rooms and wards of the
hospital within 2 months.
It is worth noting that several of the isolates preserved
identity, jointly in genotype, phenotype and susceptibility to
antibiotics, in close time but not in spatial location, such as
patients 4 and 15; 16a and b, and 36; 24b and c; 20 and 23; 28
and 31; 38 and 39; 3a and 8; and 18 and 18a.
Respiratory colonization
In four patients (3, 18, 24 and 45) a persistent identical clone
could be detected in sputum cultures separated in time. In
samples corresponding to patient 3 (3 and 3c), a coincidental
genotype was determined in samples obtained 23 months
apart.
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TABLE 1. Chronological list of isolates analysed by molecular methods, with location, number of patient, genotype, phenotype
and antibiotype codes, culture results, number of hospitalizations and number of days of hospitalizations per year previous to an
isolate and date of death
Culture date
(MM/DD/YY)
Room >
transfer Patient
Culture
resultsa ST GC PC AC FEV1%
No.
hosp/year
No.
days/year
Exitus
date (MM/YY)
03/03/06 107 1 1 2 A b m 45% 3 54
03/07/06 125 2 1 2 A a f 37% 3 179 08/06
03/16/06 AMBb 3 2 5 F a v 21% 1 15
03/21/06 113 4 1 2 A a a 29% 1 30
04/26/06 117 5 1 NR NR NR NR 25% 5 71 06/08
05/05/06 AMB 1ad 1 NR NR NR NR 45% 5 66 09/07
05/10/06 121 6 2 NR NR NR NR NA 3 69 03/07
05/18/06 AMB 7 4 6 K a d 18% 0 0
05/25/06 101 8 1 1 D a k 25% 6 40 06/08
06/22/06 105 3a 2 1 D a k 21% 1 30
07/06/06 119 > 213 9 1 NR NR NR NR 43% 1 90
10/17/06 129 9a 1 NR NR NR NR 43% 1 190
11/20/06 AMB > 101 > 125 10 1 7 M a h 30% 4 38 05/08
11/29/06 AMB 11 1 8 G a y 46% 0 0
12/13/06 129 9b 2 NR NR NR NR 43% 1 240 01/07
12/20/06 117 12 3 2 A a w 14% 2 20 01/07
12/20/06 109 13 4 1 D a m NA 4 97
01/02/07 111 14 1 NR NR NR NR 42% 2 72
01/26/07 117 > 103 15 1 2 A a a 36% 4 99 02/07
02/02/07 133 13a 2 NR NR NR NR NA 4 144 02/07
02/05/07 101 16 1 NR NR NR NR 30% 1 36
02/06/07 101 16a 1 2 A c b 30% 1 37
02/07/07 101 16b 1 2 A c b 30% 1 38
02/13/07 121 17 1 NR NR NR NR NA 1 4 08/08
02/20/07 107 > 105 > AMB 18 1 3 E d c 33% 1 27
02/23/07 123 > AMB 19 2 2 A c o 50% 2 40
02/28/07 117 > 115 20 1 4 B c a 32% 4 40
03/09/07 115 21 1 4 B e a 27% 1 35 04/07
03/13/07 121 22 1 5 F e c 97% 2 62 06/08
03/20/07 123 23 2 4 B c a 14% 3 105 01/08
04/04/07 117 18a 1 3 E d c 33% 2 41
04/14/07 103 > HSLLc 24 1 NR NR NR NR 31% 1 8
04/23/07 121 > 129 25 4 3 E d d 68% 2 31 08/07
05/14/07 418 HSLL>123 24a 2,3 NR NR NR NR 31% 1 36
05/15/07 131 26 1 NR NR NR NR 34% 1 120 06/09
06/07/07 123 24b 1 2 A c f 31% 1 55
06/13/07 AMB 18b 1 NR NR NR NR 33% 3 51
06/19/07 109 27 1 1 D a l 31% 4 40
06/19/07 111 28 1 4 B a a 48% 1 64 12/07
06/20/07 109 27a 1 NR NR NR NR 31% 4 41
07/18/07 129 29 1 NR NR NR NR 28% 3 36
07/19/07 AMB 30 1 1 D a a 45% 1 12
07/24/07 107 31 2 4 B a a 30% 2 107 06/09
07/25/07 123 24c 2 2 A c f 31% 1 123
09/20/07 119 32 1 NR NR NR NR 57% 2 51
09/25/07 117 33 1 NR NR NR NR 67% 1 17
10/22/07 127 34 1 4 B a b 48% 1 20 12/07
01/04/08 105 35 2 9 H k t 33% 4 86 07/08
01/11/08 AMB 3b 2 NR NR NR NR 21% 1 33
02/05/08 AMB 3c 2,3 5 F a h 21% 1 33 04/08
02/19/08 131 33a 2 1 D a s 67% 3 67 04/08
02/29/08 121 36 2 2 A c b 19% 1 90 06/08
03/26/08 119 32a 3,4 5 F a c 57% 2 98 10/08
04/01/08 123 37 2 3 E g d 34% 5 137
04/09/08 121 38 1 4 B b b 60% 4 46
05/12/08 107 39 1 4 B b b 59% 4 74
05/15/08 131 40 2,4 4 B f z 30% 3 87
10/09/08 105 41 1 4 B a l NA 5 70
11/28/08 204 42 1 10 L a r NA 2 50
12/01/08 103 43 1 NR NR NR NR 57% 1 38
01/13/09 230 44 1 11 C b p NA 1 39
02/04/09 103 45 1 11 C a e 57% 1 11
02/18/09 112 HGd 46 2 8 G b g 52% 1 85
02/19/09 112 HG 46a 2 8 G b g 52% 1 86
02/23/09 226 47 4 11 C b n NA 1 180 02/09
02/25/09 119 48 3 NR NR NR NR 57% 1 32
02/25/09 103 45a 4 11 C b e 19% 3 88
03/10/09 131 49 4 11 C b g 76% 4 43
03/11/09 103 45b 3 11 C h e 57% 1 46
03/31/09 119 48a 4 NR NR NR NR 19% 3 88
05/12/09 111 50 1 NR NR NR NR 61% 4 134
06/22/09 117 51 4 15 J c x 33% 2 23
In bold and with different lowercase letters the patients that appear more than once are indicated; i.e. 1a = patient no. 1, second isolate. AC, antibiotype code; GC, genotype
code; NA, not available; NR, unrecovered; PC, Phenotype code; ST, sequence type.
aCulture results: 1, C. striatum as pure culture; 2, C. striatum plus Pseudomonas aeruginosa; 3, C. striatum plus Stenotrophomonas maltophilia; 4, C. striatum plus other microorganisms.
bOutpatient.
cHospital Son Llatzer.
dHospital General.
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Outbreaks of nosocomial infection
Some episodes of clone A direct transmission affecting three
patients during March 2006 could be detected, and also of
clone B in three patients between February and March 2007
(Figs. 1 and 2, Table 1). We also identiﬁed two small
outbreaks of nosocomial infection by clone A, between
December 2006 and February 2007, and by clone C between
January and March 2009, corresponding to six and ﬁve isolates,
respectively, each affecting four patients.
From December 2006 to July 2007, 30 strains of C. striatum
were isolated from sputum specimens from 21 patients, but
the accumulation of isolates corresponded to ﬁve different
clones.
Mortality
During our study, 25 of the 51 patients (49%) died. In 15 of the
25 deaths (60%), C. striatum isolates were detected without
accompanying microbiota. When comparing deceased and
FIG. 1. Map of Respiratory ward—Hospital Joan March. a3cF: patient number 3, its fourth consecutive isolate, genotype F. bHJM 204: Hospital Joan
March, second ﬂoor, room 204. cHG 112: Hospital General, ﬁrst ﬂoor, room 112. d121: room 121, ﬁrst ﬂoor, respiratory ward, Hospital Joan March.
FIG. 2. Temporal distribution of the isolates based on the genotype code. aUnrecovered isolates. bOne isolate; cTwo isolates. dThree isolates.
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surviving participants, mean FEV1% was 33% and 40%, mean of
hospitalizations in the year before a positive culture was 2.4
and 2.1, and the average hospital stay was 80.2 days and
49.6 days, respectively (all p n.s.).
Temperature and humidity
Fig. 3 represents the 115 isolates of C. striatum recorded in our
hospital from2004 to 2009 bymonth according to calendar year.
The ﬁgure shows a trend to cluster cases in winter and spring,
consistent with low temperatures and high humidity values.
Discussion
In the pre-antibiotic era, Gram-positive bacteria were respon-
sible for most severe infections; however, since the 1940s and
with the introduction of penicillin, there has been an increase in
Gram-negative bacteria infections until the sixth and seventh
decades of the last century. Since then, a number of factors
including the widespread use of broad-spectrum antibiotics for
an increasing number of patients with severe chronic diseases,
and the implementation of more aggressive and invasive
diagnostic and therapeutic procedures have produced a
resurgence of Gram-positive bacteria with multiresistance to
antibiotics, generating both high morbidity and mortality. At the
forefront is methicillin-resistant Staphylococcus aureus, but other
genera have also acquired worrisome momentum, such as
Corynebacterium spp. [5].
With C. striatum, a number of particularities have been
repeatedly reported in a number of publications such as their
high transmissibility causing nosocomial outbreaks, highlighting
that most of the isolates belong to respiratory specimens,
frequently associated with P. aeruginosa and S. maltophilia
[7,20,21]. Advanced chronic respiratory diseases, already very
prevalent and expected to continue increasing in the near
future, become the most susceptible conditions to infectious
complications associated with this microorganism.
Outbreaks of nosocomial infection and the epidemiological
determinants of C. striatum have been studied with the
methodology available in each circumstance [15,17–22].
Although pulsed-ﬁeld gel electrophoresis is considered the
reference standard for the identiﬁcation of causative agents of
nosocomial infections or outbreaks, recent publications
[27,28] warn of the limitations for comparative studies of
long series of isolates, the difﬁculty in introducing and sharing
results on databases, the technical variability that hinders the
reproducibility of the results, and the fact that often this
method is too discriminating for a reliable determination of the
phylogenetic relatedness between isolates. We chose the
molecular typing method (MLSA) to identify and distinguish
between clones and for comparative studies between long
series of isolates. Twelve clones, nine phenotypes and 22
antibiotic susceptibility patterns were identiﬁed, establishing
the following conclusions:
Transmission
Direct transmission between patients, or through shared
space, could be postulated in some cases, including the two
small outbreaks of nosocomial infections caused by clone A
and clone C, corresponding to six and ﬁve isolates, respec-
tively, and each affecting four patients. However, most matches
occurred in samples from patients hospitalized in rooms
FIG. 3. Corynebacterium striatum isolations versus temperature (°C) and humidity (H%); C. striatum isolates in Hospital Joan March, from January
2004 to June 2009.
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located at varied distances within the same ward, or even on
different wards of the same hospital, suggesting that the
fundamental mode of transmission is from person-to-person
and through caregivers, accentuated by the wide use of
inhalation devices in the treatment of respiratory diseases, as
outlined in previous publications [16,18,20,21].
MLSA also allowed us to distinguish the grouping of 30
isolates of C. striatum in 21 patients between December 2006
and July 2007, which did not correspond to a single nosocomial
outbreak but included ﬁve different clones, and to conﬁrm that
the incidence of C. striatum infection can be high, regardless of
occasional outbreaks.
Colonization
Clones A, B and C tended to persist for long periods, and might
be isolated in the same or in different patients from 2 months up
to 2 years. It is remarkable to observe jumps of several months
between two identiﬁcations of the same clone, without knowing
if they persisted in the habitat or in colonized patients. Thirteen
patients had more than one positive culture for C. striatum
during follow up, and the greater trend was observed with the
more severe bronchial obstruction. For patient 3, three isolates
were processed within 23 months. The same clone, F, and the
same phenotype ‘a’, were identiﬁed in the ﬁrst and third samples,
varying only the antibiotype. In the intermediate sample,
3 months after the ﬁrst one, we identiﬁed a different clone,
namedD,whichwas identical to theoneobtained frompatient 8,
hospitalized at the same time in the immediately adjoining room.
So, both high transmissibility and persistence could be shown in
the same patient, with the additional predisposing determinants
to suffering a very severe bronchial obstruction (FEV1%: 21%).
Murphy et al. demonstrated the possibility of an identical
Haemophilus inﬂuenzae clone persisting in the airways of the
same patient even when in intermediate periods between two
isolates negative sputum cultures were obtained, demonstrating
that sputum cultures underestimate the frequency of H. inﬂu-
enzae colonization in the respiratory tract [29].
The relationship between accumulation of infections by an
environmental pathogen such as C. striatum and environmental
circumstances was explored with temperature and humidity
values obtained at the date of each isolate, identifying a
clustering during periods of low temperatures and high
humidity. This observation can only have a speculative value,
but we present it for comparison with future studies.
Adaptive ability
In the 42 isolates of C. striatum, nine phenotypic variants were
identiﬁed that, when added to the 12 molecular clones,
produces 23 different combinations, showing a high adaptive
variability.
Antibiotic resistance
With regards to C. striatum antibiotic susceptibility, we
obtained 22 different combinations, a key ﬁnding being that
all isolates fulﬁl the criteria for multidrug-resistance. Actually,
the most frequent variants were: sensitivity only to vancomy-
cin (eight isolates, 16.3%) and sensitivity only to vancomycin
and gentamicin (six isolates, 12.2%). Coincidentally with all
previous publications 100% of the isolates were sensitive to
vancomycin. Finally, all our isolates were resistant to cipro-
ﬂoxacin.
Earlier publications [12,14,30], still described strains with
broad sensitivity to antibiotics, and in fact the type strain of
C. striatum was resistant to cefotaxime only [23]. But in all later
publications, nosocomial outbreaks described in intensive care
areas [16,18] and other places [17,19,20,22] the multidrug
resistance was a constant ﬁnding, which proves the high
adaptability of C. striatum to antibiotic pressure. Pulmonary
perfusion defects associated with bronchial obstruction in
chronic respiratory illnesses can play an important role in this
circumstance, making it difﬁcult to achieve optimal therapeutic
concentrations of antibiotics, which facilitates the selection of
resistant strains and their persistence in the airways.
As vancomycin is the only antibiotic with sure efﬁcacy
against C. striatum it might pose a threat to antibiotic policies,
because it competes as reserve antibiotic of choice against
methicillin-resistant Staphylococcus aureus.
The molecular mechanisms of resistance to antibiotics of
C. striatum are poorly understood. The plasmid pTP10, whose
genetic material is capable of encoding 16 antimicrobial
resistances, the acquisition of a speciﬁc transposon (Tn5432),
and genes related with antibiotic resistance have already been
characterized elsewhere [19,22,23,31,32]. Further studies are
needed to clarify the mechanisms of multidrug resistance to
antibiotics in C. striatum.
Morbidity and mortality
Information about C. striatum virulence factors is limited. In
addition, their causality associated with mortality of C. striatum
infection is highly variable and often speculative.
Regarding morbidity, there is a broad agreement on the
factors predisposing to infection by C. striatum, as previously
discussed. There is an increased frequency of repeated
isolations the greater is the degree of bronchial obstruction,
as measured by FEV1%.
The high mortality rates observed in our study can be partly
attributed to the severity of respiratory disease, and also to
the infectious exacerbation of disease by C. striatum. On the
one hand, we noted a worse FEV1% and more admissions and
hospital stays among deceased patients versus survivors. With
regards to infection by C. striatum, the 18 deaths among the 42
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patients who could complete the molecular study, were
accumulated in clones A, B, D and F, and in phenotype ‘a’, but
without statistical signiﬁcance. However, the trend towards
increased mortality in patients who suffered respiratory
infections by bacterial strains with broader multidrug-resis-
tance (four susceptible to vancomycin only, and two others to
vancomycin and gentamicin) should be noted.
The main strengths of our study are the accuracy of the
correct identiﬁcation of the isolates involved in respiratory
infections by C. striatum, in a homogeneous group of patients
within a deﬁned physical space, and over a long period of time
to facilitate monitoring. These factors helped to follow the
path of each clone and their epidemiological patterns. A major
limitation is the loss of 23 unrecovered isolates obtained
during this period, belonging to nine patients.
To conclude, C. striatum is a health concern because it is an
emergent Gram-positive environmental bacterium, prevalent,
highly persistent and transmissible person-to-person and
through caregivers, with usual multidrug resistance, that can
cause opportunistic severe infection and long-term airway
colonization in patients with advanced chronic respiratory
disease (older, more obstructed and poorly perfused, with
frequent and prolonged hospitalizations, exposed to repeated
cycles of antibiotics), and often the cause of outbreaks of
respiratory nosocomial infection. Prevention should be based
on guideline-based management of advanced respiratory
disease and its frequent exacerbations, enforcing hygiene
measures in caregivers and therapeutic devices, and treatment
according to antibiogram or, should it be unavailable, with
vancomycin.
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